We are live on
!
Find out more
RC
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter
Est. Return
+10.13%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$1.04B
AUM Growth
+$118M
(+13%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-11.34%
Top 10 Holdings %
Top 10 Hldgs %
28.39%
Holding
366
New
27
Increased
101
Reduced
180
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KYTH
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
|
+$8.02M |
| 2 |
Goldman Sachs
GS
|
+$4.67M |
| 3 |
Citigroup
C
|
+$1.86M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.39M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$96.4M |
| 2 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$48.6M |
| 3 |
DELL
DELL INC
DELL
|
+$2.92M |
| 4 |
Cboe Global Markets
CBOE
|
+$822K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$488K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.14% |
| 2 | Financials | 11.65% |
| 3 | Technology | 11% |
| 4 | Energy | 9.38% |
| 5 | Industrials | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
iShare MSCI Eurozone ETF
EZU
$9.35B
| – | – |
-2,437,616
| Closed | -$96.4M |
|
|
AMJ
2
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| – | – |
-1,076,555
| Closed | -$48.6M |
|
3
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $25.7M | 2.49% |
625,232
+21,044
| +3% | +$868K |
|
4
ExxonMobil
XOM
$651B
| $18.9M | 1.83% |
187,019
-14
| -0% | -$1.29K |
|
5
Chevron
CVX
$388B
| $17.5M | 1.7% |
140,468
+2,715
| +2% | +$328K |
|
6
CVS Health
CVS
$136B
| $16.5M | 1.6% |
231,230
+1,812
| +0.8% | +$116K |
|
7
Pfizer
PFE
$142B
| $15.6M | 1.5% |
535,087
+24,838
| +5% | +$723K |
|
8
Comcast
CMCSA
$78.9B
| $15.5M | 1.5% |
597,970
-702
| -0.1% | -$16.9K |
|
9
Apple
AAPL
$4.72T
| $15.4M | 1.49% |
771,064
+19,628
| +3% | +$371K |
|
10
Northrop Grumman
NOC
$75.5B
| $14.2M | 1.37% |
123,593
+442
| +0.4% | +$47.3K |
|
|
TWX
11
DELISTED
Time Warner Inc
TWX
| $13.7M | 1.33% |
205,679
+2,569
| +1% | +$166K |
|
12
iShares Micro-Cap ETF
IWC
$1.44B
| $13.6M | 1.32% |
181,701
-5,076
| -3% | -$361K |
|
13
Walt Disney
DIS
$162B
| $13.2M | 1.28% |
173,222
-2,511
| -1% | -$174K |
|
14
Johnson & Johnson
JNJ
$624B
| $12.8M | 1.24% |
139,826
+2,573
| +2% | +$237K |
|
15
Intel
INTC
$502B
| $12.1M | 1.17% |
467,410
+1,785
| +0.4% | +$43.2K |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $11.1M | 1.07% |
161,797
+1,120
| +0.7% | +$73.1K |
|
17
Xerox
XRX
$337M
| $10.8M | 1.05% |
337,816
+3,894
| +1% | +$112K |
|
18
ConocoPhillips
COP
$147B
| $10.6M | 1.02% |
150,018
+555
| +0.4% | +$39.9K |
|
19
Thermo Fisher Scientific
TMO
$213B
| $10.5M | 1.01% |
93,855
-1,193
| -1% | -$119K |
|
20
UnitedHealth
UNH
$385B
| $10.2M | 0.99% |
136,013
-1,094
| -0.8% | -$78.6K |
|
|
LLL
21
DELISTED
L3 Technologies, Inc.
LLL
| $10.2M | 0.99% |
95,432
+3,780
| +4% | +$378K |
|
22
GE Aerospace
GE
$361B
| $9.92M | 0.96% |
73,858
-22
| -0% | -$2.77K |
|
23
Microsoft
MSFT
$2.82T
| $9.73M | 0.94% |
260,198
+13,231
| +5% | +$481K |
|
|
24
Citigroup
C
$222B
| $9.65M | 0.93% |
185,230
+36,786
| +25% | +$1.86M |
|
25
IBM
IBM
$193B
| $9.57M | 0.92% |
53,361
-715
| -1% | -$123K |
|
Similar funds
5L
W
MA
APA
MIAN
CCM
AC
DY
RegentAtlantic Capital's Q4 2013 Portfolio in Review
As of Q4 2013, RegentAtlantic Capital held 366 positions worth $1.04B, up 13% from $917M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
RegentAtlantic Capital withdrew a net $117M in Q4 2013, closing 13 positions and reducing 180 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $96.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
Against the trend, RegentAtlantic Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM worth $7.23M.
- RegentAtlantic Capital's largest Q4 2013 buy was KYTHERA BIOPHARMACEUTICALS, INC COM: 193,454 shares worth $7.23M.
- RegentAtlantic Capital added most to Goldman Sachs in Q4 2013, an estimated $4.67M increase.
- RegentAtlantic Capital's biggest Q4 2013 reduction was Cboe Global Markets, cutting an estimated $822K.
- RegentAtlantic Capital fully exited iShare MSCI Eurozone ETF in Q4 2013, selling an estimated $96.4M.
- RegentAtlantic Capital's ten largest holdings make up 28% of its $1.04B portfolio in Q4 2013.
- RegentAtlantic Capital opened 27 new positions and closed 13 in Q4 2013.
- RegentAtlantic Capital's portfolio value rose 13% quarter-over-quarter to $1.04B.
Based on RegentAtlantic Capital's 13F filing for Q4 2013, filed 31 Jan 2014.